Want to position yourself at the forefront of autoimmune and inflammatory model optimization?
The inaugural Autoimmune & Inflammatory Models Summit is the first industry focused forum tackling translation gaps in in autoimmune drug development. Uniting leading experts from AbbVie, Bristol Myers Squibb, and Pfizer, this event focuses on in vitro and in vivo models, IND strategies, and FDA compliance precisely where you can add critical value.
This forum delivers direct access to decision-makers evaluating partners for model translatability and regulatory success. For preclinical CROs, assay developers and imaging providers, this is your unmatched opportunity to position your solutions as essential to advancing next-generation therapies.
Don't miss the only industry-led event for optimizing autoimmune & inflammatory preclinical discovery!
Autoimmune & Inflammatory Drug Developers Need Your Help With:
Why Partner in 2025?
Master the FDA's new model requirements and develop compliant solutions to help biopharma clients successfully transition from animal model testing to alternative approaches
Uncover industry-critical pain points to develop precisely targeted solutions that address your client's most pressing preclinical challenges
Elevate your market position by showcasing differentiated capabilities that address the industry's most pressing translational challenges in autoimmune and inflammatory preclinical development
Who You Can Connect With:
Join the 2025 Event Partner:
GemPharmatech
Expertise Partner
GemPharmatech is a global contract research organization that provides genetically engineered mouse models and preclinical research services to the scientific community. We have an extensive library of over 25,000 models including KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice, and continually expand our library to assist our customers in achieving their research goals. To further support our customers, we also offer custom model generation, breeding, and compound efficacy testing in our offices across China and in our new large-scale vivarium and laboratory in San Diego.
Biocytogen
Expertise Partner
Biocytogen is a global biotech company advancing antibody drug development through innovative technologies. Leveraging gene-editing expertise, it pioneered drug target knock-in humanized models and offers 3,000+ models via BioMice, alone with in vivo, ex vivo, and in vitro pharmacology and custom gene-editing services. Biocytogen drives fully human monoclonal antibody discovery and offers 4000,000+ antibody sequences targeting 1,000 proteins through its RenBiologics sub-brand for global partnerships.